Posterior Colporrhaphy (Rectocele Repair) — Prolapse Surgery Guide & Outcomes — Cost, Top Hospitals & Success Rates | MyMedicPlus

Posterior colporrhaphy — commonly called a posterior repair — is a vaginal reconstructive surgical procedure designed to correct posterior vaginal wall prolapse, most commonly a rectocele: a herniation of the rectum into the posterior vaginal wall resulting from weakness and attenuation of the rectovaginal fascia (Denonvilliers' fascia) and its supporting connective tissue. The procedure involves a midline posterior vaginal incision, dissection of the vaginal skin laterally to expose the underlying fascial layer, plication or repair of the attenuated rectovaginal fascia, removal of redundant vaginal epithelium, and layered wound closure. Perineorrhaphy (reconstruction of the perineal body) is frequently performed concurrently to restore introital integrity.

The severity of rectocele and posterior vaginal wall prolapse is quantified using the internationally validated Pelvic Organ Prolapse Quantification (POP-Q) system, endorsed by the International Urogynecological Association (IUGA) and International Continence Society (ICS): Stage I — leading edge more than 1 cm above the hymen (usually asymptomatic); Stage II — leading edge within 1 cm either side of the hymen; Stage III — leading edge more than 1 cm below the hymen; Stage IV — complete eversion of the posterior vaginal wall. Surgery is generally indicated for symptomatic Stage II–IV prolapse that has not responded to conservative management.

The NICE Clinical Guideline NG123 (2019, updated 2021) specifies that pelvic floor muscle training (PFMT) delivered by a specialist pelvic floor physiotherapist is the recommended first-line treatment for all grades of prolapse. Women should undertake a supervised PFMT programme for a minimum of 3–6 months before surgical referral for Stage I–II prolapse. A vaginal pessary (ring, shelf, or Gellhorn device) represents a well-established non-surgical intermediate option for women who prefer to avoid or delay surgery, or who are not fit for general anaesthesia. Surgery is reserved for women who have failed conservative management, present with Stage III–IV prolapse, or have significant functional impairment.

Posterior colporrhaphy is designed to address symptomatic defects in the posterior compartment of the pelvic floor. The primary and associated conditions include:

• Rectocele (posterior vaginal wall prolapse): Herniation of the anterior wall of the rectum through the rectovaginal fascia into the posterior vaginal lumen. Presents with a vaginal bulge (often worse at the end of the day or after prolonged standing), pelvic pressure, difficulty with defaecation (incomplete rectal evacuation, the need to digitally reduce the prolapse to defaecate — called digitation), and straining. This is the primary and most common indication for posterior colporrhaphy.
• Enterocele: Small bowel herniation through the peritoneum into the posterior vaginal fornix; may coexist with rectocele; diagnosed clinically during bimanual examination (bowel loops felt above the rectocele on Valsalva) or confirmed on defaecating proctogram or MRI defaecography. Requires a high posterior repair (obliteration of the cul-de-sac of Douglas) in addition to standard colporrhaphy.
• Posterior vaginal wall laxity with perineal descent: Widening of the introitus following obstetric trauma, with perineal descent and introital laxity causing pelvic heaviness and difficulty with sexual intercourse; addressed by concurrent perineorrhaphy.
• Recurrent rectocele after prior prolapse repair: Symptomatic recurrence after a previous posterior colporrhaphy; may require mesh augmentation with biological graft in highly selected cases after thorough informed consent.
• Multi-compartment pelvic organ prolapse: Rectocele commonly coexists with cystocele (anterior compartment) and uterine or vault prolapse (apical compartment); combined anterior and posterior repair — with or without apical vault suspension — is performed in 40–60% of cases presenting to urogynaecology units.

Women with symptomatic posterior vaginal wall prolapse are candidates for posterior colporrhaphy if they meet the following criteria:

• POP-Q Stage II or higher: The leading edge of the posterior vaginal wall is at or below the hymenal ring on clinical examination (POP-Q point Bp ≥ −1 cm); isolated Stage I prolapse is rarely an indication for surgery.
• Failed conservative management: A structured pelvic floor muscle training (PFMT) programme supervised by a specialist physiotherapist for a minimum of 3 months (NICE NG123 recommendation), combined with a pessary trial where appropriate. Physiotherapy reduces prolapse by at least one stage in 40–50% of women with mild-to-moderate prolapse.
• Significant quality-of-life impact: Symptoms cause meaningful functional limitation assessed by validated patient-reported outcome measures (PFDI-20, PFIQ-7); prolapse-related sexual dysfunction; inability to defaecate without digital assistance; or chronic pelvic heaviness affecting daily activities and employment.
• Completed or not planning further childbearing: Vaginal delivery after posterior repair may disrupt the repair; women should ideally have completed their family before surgery, or be counselled that subsequent vaginal delivery increases recurrence risk and that elective caesarean section could be discussed.
• Medically fit for anaesthesia: ASA grade I–III; general or regional (spinal) anaesthesia is acceptable; spinal anaesthesia is preferred in elderly patients to reduce cognitive effects.
• Realistic expectations: Fully informed of subjective success rates (75–90% at 12 months with native tissue repair), recurrence rates (10–30% at 5 years), dyspareunia risk (10–15%), and the non-recommendation of synthetic mesh for primary repair.

Women with predominant bowel symptoms (constipation, obstructed defaecation) without a clinically significant bulge should be referred for colorectal assessment and defaecating proctogram before surgical referral to a urogynaecologist, as the benefit of posterior colporrhaphy for isolated obstructed defaecation without prolapse is uncertain.

Traditional midline plication (posterior colporrhaphy) — most widely performed:

A midline posterior vaginal incision is made from the vaginal apex to the hymenal ring. The vaginal epithelium is dissected off the underlying rectovaginal fascia using sharp and blunt dissection. The fascial layer is plicated in the midline using interrupted or running absorbable sutures (polyglycolic acid or PDS). Redundant vaginal skin is excised judiciously — over-resection narrows the vaginal calibre and contributes to postoperative dyspareunia. The incision is closed with running absorbable suture. Operating time is 30–60 minutes for an isolated posterior colporrhaphy.

Levator ani plication:

Addition of sutures approximating the medial bellies of the levator ani muscles below the vaginal repair. Historically common but now used selectively, as levator plication significantly increases the risk of postoperative dyspareunia (from approximately 10% to 20–25% in comparative series). NICE NG123 advises specific informed consent when levator plication is planned.

Site-specific defect repair (Richardson technique):

Based on the DeLancey defect theory (1999) that rectoceles result from discrete breaks in the rectovaginal fascia at specific anatomical sites, rather than generalised attenuation. Defects are identified intraoperatively and repaired individually with targeted sutures. A randomised controlled trial by Paraiso et al. (2006) found no significant difference in anatomical or functional outcomes compared to traditional midline plication at 12 months, though site-specific repair may produce less narrowing of vaginal calibre in theory.

Augmented repair:

• Biological mesh (porcine dermal collagen, cadaveric fascia lata): Used to reinforce native tissue in recurrent prolapse or significantly attenuated tissue. Biological grafts avoid the specific complications of synthetic polypropylene mesh. Short-term anatomical improvement demonstrated; long-term data limited.
• Synthetic polypropylene mesh (NOT recommended for primary repair): NICE NG123 (2019) and NHS England restrictions do not recommend transvaginally placed synthetic mesh for primary posterior vaginal prolapse repair, citing serious mesh-specific complications including erosion/exposure (4–10%), chronic pelvic pain, dyspareunia, and mesh contraction. Restricted to specialist centres managing complex or recurrent cases under strict audit.

Combined procedures:

Posterior colporrhaphy is frequently performed alongside anterior colporrhaphy (cystocele repair), sacrospinous ligament fixation or uterosacral ligament suspension (vault or uterine prolapse), vaginal hysterectomy for uterine prolapse, and tension-free vaginal tape (TVT) or transobturator tape (TOT) for concurrent stress urinary incontinence. NICE NG123 advises that all symptomatic compartments be corrected simultaneously where feasible.

When performed in appropriately selected women after failure of conservative management, posterior colporrhaphy delivers consistent, validated benefits:

• Relief of vaginal bulge: 75–90% of women report subjective cure or significant improvement in prolapse symptoms at 12 months with native tissue posterior repair (Cochrane Review, Maher et al. 2018).
• Improved defaecatory function: Resolution of the need for digitation to defaecate in 60–75% of women; reduction in straining and incomplete rectal evacuation; most patients note immediate functional improvement after surgery as the rectovaginal dead space is eliminated.
• Resolution of pelvic pressure and heaviness: The most reliably improved symptom across all outcome studies; almost all women with Stage III–IV prolapse experience significant relief in pelvic heaviness within weeks of surgery.
• Improved sexual function: The majority of sexually active women report improved sexual function postoperatively, although this must be balanced against the 10–15% dyspareunia risk, particularly when levator plication is performed.
• High patient satisfaction: 85–90% of women in prospective registry data state they would choose posterior repair again at 12 months; this figure decreases to approximately 75–80% at 5 years, tracking prolapse recurrence rates.
• Avoidance of mesh complications: Native tissue posterior repair carries no risk of the serious mesh-specific complications (exposure, contraction, pelvic pain, dyspareunia) associated with synthetic transvaginal mesh — supporting the NICE NG123 guidance against routine mesh use.
• Short recovery: 1–2 days hospital stay; return to non-physical work at 2–4 weeks; full activity restoration at 6–8 weeks.
• Durable outcomes: 70–80% of women maintain subjective satisfaction at 5 years in prospective studies; anatomical recurrence rates of 20–30% at 5 years are higher than subjective recurrence rates, reflecting that mild anatomical recurrence does not always produce significant symptoms.

Women considering posterior colporrhaphy should be fully informed of the following recognised risks through a structured consent process:

• Dyspareunia (painful intercourse): New or worsened superficial dyspareunia in 10–15% of sexually active women; most commonly introital or at the mid-vagina. Risk is significantly higher when levator ani plication is performed (rising to 20–25%). Usually improves over 6–12 months with pelvic floor physiotherapy, vaginal dilators, and topical oestrogen in post-menopausal women. Persistent severe dyspareunia requiring surgical revision in 1–3% of cases.
• Prolapse recurrence: Symptomatic recurrent rectocele at Stage II or higher in 10–30% of women at 5 years; anatomical recurrence is detected in up to 40%. Higher recurrence rates are associated with: connective tissue disorders (Ehlers-Danlos syndrome), obesity (BMI >30), chronic straining, previous pelvic floor surgery, and inadequate apical support at the time of primary repair.
• Constipation and obstructed defaecation: New-onset or worsened constipation in 15–25% of patients; mechanism relates to reduction in posterior vaginal wall flexibility and possible narrowing of the anorectal angle. Managed with dietary fibre, adequate hydration, stool softeners, and biofeedback therapy. Rarely permanent.
• De novo stress urinary incontinence (SUI): Unmasked occult SUI in 10–15% of women after prolapse repair (removal of the urethral kinking effect of the prolapse). Pre-operative urodynamic assessment with the prolapse reduced is recommended if occult SUI is suspected clinically or on assessment.
• Haemorrhage: Intraoperative haemorrhage requiring transfusion in under 1%; post-operative vault haematoma in 2–5% (most resolve spontaneously but may require aspiration or drainage); secondary haemorrhage at 5–14 days post-operatively in 1–3%.
• Wound infection and vault cellulitis: Superficial wound infection or vault cellulitis in 2–5%; urinary tract infection (catheter-associated) in 5–15%; prophylactic IV cefazolin at induction reduces SSI risk. Treated with a short course of antibiotics.
• Urinary retention: Transient retention requiring catheterisation post-operatively in 5–10%; almost always resolves within 24–48 hours; long-term voiding dysfunction is rare (<0.5%).
• Rectal injury: Buttonhole injury to the anterior rectal wall during dissection in under 0.5% of cases; recognised and repaired intraoperatively in layers; dietary modification (low-fibre diet temporarily) and antibiotic cover required post-repair.

Hospital (Days 0–2):

• Urinary catheter removal at 24 hours with trial of voiding; monitor post-void residual volume.
• Analgesia: Regular paracetamol and NSAID (diclofenac or ibuprofen); opioid rescue for severe pain.
• Commence stool softener (lactulose or docusate sodium) from day 1 to prevent straining at stool during healing.
• Discharge day 1–2 for uncomplicated cases; written discharge instructions regarding activity restrictions, analgesia, and wound care.

2 weeks:

• GP or community nurse wound review; assessment of healing and perineal comfort.
• Activity advice: Gentle daily walks; avoid heavy lifting (>3 kg); shower only (no baths for 2 weeks); no sexual intercourse; no swimming; no driving.

6 weeks:

• Clinic review with urogynaecologist or gynaecologist; vaginal examination assessing healing and prolapse correction; discussion of resumption of sexual intercourse and return to full activity.
• Referral to specialist pelvic floor physiotherapist if not completed pre-operatively — PFMT is recommended from week 4 onwards and should continue lifelong to maintain results.

3 months:

• Patient-reported outcome measures assessed (PFDI-20, PISQ-12 for sexual function); functional review; management of persistent constipation, defaecatory symptoms, or early dyspareunia.

6–12 months:

• Final routine urogynaecology review; POP-Q re-staging; discharge if anatomically and symptomatically satisfactory; advice on long-term prolapse prevention.

Long-term advice: Lifelong pelvic floor exercises (Kegel exercises); dietary fibre and adequate fluid intake to prevent constipation; maintenance of healthy BMI; avoidance of heavy lifting as a chronic lifestyle pattern; prompt re-referral if symptoms of recurrence develop. Post-menopausal women should consider topical vaginal oestrogen (where not contraindicated) to maintain vaginal tissue quality and reduce recurrence risk.

Posterior colporrhaphy costs vary significantly by country, healthcare sector, and whether combined procedures are performed:

United Kingdom (NHS):

• Posterior colporrhaphy is commissioned on the NHS under standard gynaecological surgery tariffs; not subject to the commissioning restrictions applied to transvaginal mesh procedures.
• NHS HRG tariff for vaginal repair: approximately £2,000–3,500 for isolated posterior colporrhaphy; £4,000–7,000 for combined anterior-posterior repair with vault suspension.
• NHS waiting times: typically 12–24 months on the elective waiting list.
• Private surgery (UK): £3,000–7,000 for isolated posterior repair; £6,000–12,000 for combined procedures, depending on surgeon and hospital.

International pricing (approximate USD):

• India: $800–2,500 (isolated posterior repair); $1,500–4,000 (combined procedure) at NABH/JCI-accredited hospitals
• Thailand: $2,000–4,500 at internationally accredited private hospitals
• Turkey: $1,500–4,000
• UAE: $3,000–6,000

Key cost drivers:

• Combined procedures: Each additional compartment repair (anterior, apical) adds 20–40% to the base procedure cost
• Biological mesh augmentation: Adds £500–2,000 material cost in the UK private sector
• Anaesthetic type: General vs spinal — difference of £200–500
• Surgeon grade: Consultant specialist urogynaecologist vs general gynaecologist in private practice
• Post-operative complications: Readmission for haematoma, infection, or urinary retention adds significant cost
• Pelvic floor physiotherapy: A supervised 6-month programme costs £500–1,500 privately in the UK; included within NHS physiotherapy services for most areas

Multiple evidence-based alternatives to posterior colporrhaphy exist and should be offered sequentially before surgical referral:

• Pelvic floor muscle training (PFMT): NICE NG123 mandates this as the first-line treatment for all grades of posterior vaginal prolapse. A supervised programme of at least 8 clinic sessions with a specialist pelvic floor physiotherapist over 3–6 months is superior to unsupervised exercises. The POPPY trial (Hagen et al., Lancet 2014, n=447) demonstrated that individualised PFMT significantly reduces prolapse symptoms and stage compared to a lifestyle advice leaflet alone. Reduces prolapse by at least one POP-Q stage in 40–50% of women.
• Vaginal pessaries: Ring, shelf (Gellhorn), or cube pessaries mechanically support the prolapse without surgery; suitable for women who decline surgery, are medically unfit, wish to delay surgery, or are not yet certain about completing childbearing. Effective symptom control in 60–70% of women who continue use at 1 year. Requires quarterly review and pessary change or self-management training; complications include vaginal discharge, discomfort, and rarely erosion (<5% with regular review).
• Conservative bowel management: Biofeedback therapy, dietary modification (high-fibre diet, adequate hydration), and pelvic floor physiotherapy for women whose predominant symptom is constipation or obstructed defaecation rather than vaginal bulge; often effective as first-line and useful as an adjunct post-operatively.
• Laparoscopic ventral mesh rectopexy (LVMR): A colorectal surgical approach for high-grade rectocele with obstructed defaecation syndrome (ODS) or full-thickness rectal prolapse; uses polypropylene mesh attached ventral to the rectum and secured to the sacral promontory; avoids the vaginal approach and transvaginal mesh complications; referral to a specialist colorectal surgeon is required; most appropriate when ODS is the dominant symptom.
• Topical vaginal oestrogen: For post-menopausal women, topical oestrogen (oestradiol cream or pessary) improves vaginal tissue quality, reducing symptoms of Stage I–II prolapse and improving outcomes of PFMT; used as an adjunct to other treatments rather than standalone therapy for significant prolapse.
• Watchful waiting with active monitoring: Appropriate for asymptomatic or mildly symptomatic Stage I–II prolapse; prolapse rarely progresses rapidly; regular review with PFMT maintenance is a safe strategy; symptoms often plateau or improve with lifestyle optimisation (weight management, constipation avoidance).